Rowan Chapman


Rowan Chapman,

Head, Johnson & Johnson Innovation, West North America and Australia & New Zealand – Located at the Innovation Center in South San Francisco.

Rowan is the Head of Johnson & Johnson Innovation, California. In this role, Rowan leads the California team to build and manage a portfolio of co-investments spanning all three sectors of Johnson & Johnson. 

Rowan most recently served as Head of Healthcare Investing, GE Ventures. There she led the team responsible for GE Ventures’ healthcare investing strategy and portfolio as well as managing partnerships and thought leadership with a particular focus on digital health, data analytics and precision medicine. In this role she drove creation of the first three Healthcare “NewCos” incubated and launched from GE. Prior to joining the ventures team, Rowan served as Head of Precision Diagnostics at GE Healthcare, where she was responsible for strategy development to integrate lab services, products, data, informatics, software, and content. Before GE, she spent 11 years as a Partner at Mohr Davidow Ventures, where she drove development of the life science investment strategy and practice area. Her investments ranged from therapeutics to diagnostic to digital.  

Rowan holds a PhD and first class honors degree in Biochemistry from Cambridge University, U.K. and was a post-doctoral fellow at the University of California, San Francisco.


Neomed (Montreal)
7171 Frederick-Banting
Montreal, Quebec, CANADA H4S 1Z9
(514) 367 1212
Your web browser is out of date. For the most optimal experience, please upgrade to the newest version of IE. Thank You.